Tag:
Taris Biomedical
Latest Headlines
Latest Headlines
Taris advances human testing of bladder pain treatment delivery device
Taris Biomedical has begun enrolling subjects for a Phase II clinical study designed to test its unusual LiRIS drug delivery system in patients with the bladder condition known as interstitial
Taris Biomedical raises $18.3M for bladder drug delivery
Taris Biomedical, a drug-delivery company based in Lexington, MA, has raised $18.3 million in Series B financing. The company develops targeted therapies using drug delivery to treat bladder
Drug delivery expert helps Taris through bladder disease trials
Taris Biomedical has tapped a drug-delivery expert to help take over the helm of the Lexington, MA, based specialty pharmaceutical company. Sarma Duddu, formerly a VP for drug delivery technologies
New Langer start-up garners $15M in Series A
Lexington, MA-based start-up Taris Biomedical has snared $15 million in its Series A, which will be put to use advancing a new drug-device therapy for bladder disease. Taris had been flying under the
